| Literature DB >> 16923183 |
Charles Maynard1, Haili Sun, Elliott Lowy, Anne E Sales, Stephan D Fihn.
Abstract
BACKGROUND: It is uncertain whether black white differences in the use of percutaneous coronary intervention (PCI) persist in the era of drug eluting stents. The purpose of this study is to determine if black veterans with acute myocardial infarction (AMI) are less likely to receive PCI than their white counterparts.Entities:
Mesh:
Year: 2006 PMID: 16923183 PMCID: PMC1560119 DOI: 10.1186/1472-6963-6-107
Source DB: PubMed Journal: BMC Health Serv Res ISSN: 1472-6963 Impact factor: 2.655
Baseline demographics, medical histories, and prior cardiac medications by race
| Mean age (years) | 67 ± 13 | 70 ± 11 | <0.0001 |
| Age | <0.0001 | ||
| < 50 | 9% | 3% | |
| 50–59 | 27% | 18% | |
| 60–64 | 9% | 11% | |
| 65–69 | 8% | 11% | |
| 70–79 | 26% | 32% | |
| 80–89 | 18% | 22% | |
| 90+ | 2% | 2% | |
| Men | 99% | 98% | 0.08 |
| Body mass index | 27.0 ± 6.0 | 28.0 ± 6.0 | <0.0001 |
| Miles from home to hospital | 22 ± 88 | 41 ± 116 | <0.0001 |
| Geographic region of medical center | <0.0001 | ||
| Northeast | 16% | 15% | |
| South | 52% | 43% | |
| Midwest | 21% | 21% | |
| West | 11% | 20% | |
| Myocardial infarction | 25% | 28% | 0.14 |
| Lipid disorder | 55% | 64% | <0.0001 |
| Coronary angioplasty | 12% | 14% | 0.14 |
| Coronary artery bypass surgery | 10% | 24% | <0.0001 |
| Congestive heart failure | 33% | 31% | 0.43 |
| Diabetes mellitus | 28% | 23% | 0.004 |
| Renal disease | 18% | 13% | <0.0001 |
| Cerebrovascular disease | 9% | 8% | 0.46 |
| Chronic obstructive pulmonary disease | 13% | 23% | <0.0001 |
| Dementia | 19% | 15% | 0.016 |
| Cancer | 10% | 10% | 0.81 |
| Cigarette smoking in past year | 41% | 31% | <0.0001 |
| Aspirin | 48% | 49% | 0.52 |
| Beta blockers | 51% | 54% | 0.13 |
| Angiotensin converting enzyme inhibitors | 50% | 47% | 0.24 |
| Lipid lowering agents | 48% | 53% | 0.031 |
| Insulin | 13% | 14% | 0.61 |
| Platelet inhibitors | 11% | 12% | 0.20 |
AMI Acute myocardial infarction
Presenting signs and symptoms
| Time from symptom onset to hospital admission | |||
| ≤ 1 hour | 5% | 6% | 0.12 |
| 1–2 hours | 9% | 10% | |
| 2–6 hours | 20% | 24% | |
| 6–12 hours | 13% | 13% | |
| 12–24 hours | 17% | 13% | |
| > 24 hours | 36% | 34% | |
| Heart rate | 87 ± 25 | 87 ± 23 | 0.75 |
| Systolic blood pressure | 143 ± 33 | 138 ± 31 | <0.0001 |
| Diastolic blood pressure | 80 ± 20 | 75 ± 19 | <0.0001 |
| Symptoms | |||
| Chest pain | 56% | 58% | 0.39 |
| Pressure | 17% | 18% | 0.58 |
| Belching | 6% | 4% | 0.23 |
| Shoulder pain | 21% | 30% | <0.0001 |
| Nausea | 22% | 18% | 0.031 |
| Diaphoresis | 14% | 17% | 0.09 |
| Dyspnea | 45% | 43% | 0.36 |
Treatments, transfer status, in-hospital events, and mortality
| Cardiac catheterization ≤ 30 days from admission | 59% | 57% | 0.52 |
| Percutaneous coronary intervention ≤ 12 hours from admission | 8% | 8% | 0.80 |
| Percutaneous coronary intervention ≤ 30 days from admission | 32% | 40% | <0.0001 |
| Drug eluting stent | 7% | 10% | 0.024 |
| Transfer to another hospital for percutaneous coronary intervention | 8% | 15% | <0.0001 |
| Coronary artery bypass graft surgery ≤ 30 days from admission | 5% | 8% | 0.001 |
AMI Acute myocardial infarction